Brand-name drug companies continue to break research and development spending promise.
- Published in:
- Canadian Medical Association Journal (CMAJ), 2010, v. 182, n. 11, p. E519
- By:
- Publication type:
- Article
Works matching DE "CANADA. Patented Medicine Prices Review Board"
Results: 4
1
2
Brand-name drug companies fail to meet R&D commitments.
- Published in:
- Canadian Medical Association Journal (CMAJ), 2006, v. 175, n. 4, p. 344, doi. 10.1503/cmaj.060883
- By:
- Publication type:
- Article
3
Drug pricing reforms promising but problematic.
- Published in:
- 2017
- By:
- Publication type:
- journal article
4
Canada's Pharmaceutical Price Control Paradox.
- Published in:
- Fraser Forum, 2005, p. 12
- By:
- Publication type:
- Article